Drugs / Amlodipine+valsartan
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00523744 | Jul → Dec 2007 | hypertensive disorder | Novartis | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amlodipine+valsartan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00523744 ↗ |
| Route | Oral | “Fixed-dose combination of amlodipine 10 mg plus valsartan 160 mg tablet taken orally once a day during Treatment Phase 2 and Extension Phase.” NCT00523744 ↗ |